VarCov Co’s UiPath PATH Stock Holding History

VarCov Co’s Portfolio PATH Stock Details PATH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$273K	Buy	+25,108	New	+$268K	0.1%	289
2026 Q1	–	Sell	-14,242	Closed	-$233K	–	569
2025 Q4	$233K	Buy	+14,242	New	+$222K	0.09%	380

Other funds holding PATH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

VarCov Co's PATH Position: Q2 2026 in Review

VarCov Co opened a new position in UiPath (PATH) in Q2 2026: 25,108 shares worth $273K. The stake represents 0.1% of the portfolio and ranks #289 among its holdings. This is a return to the name: VarCov Co previously reported a position in PATH as recently as Q4 2025.

VarCov Co first reported a position in PATH in Q4 2025 and has held it in 2 quarters since. 524 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

VarCov Co held 25,108 shares of UiPath worth $273K as of Q2 2026.
UiPath was a new VarCov Co position in Q2 2026.
UiPath made up 0.1% of VarCov Co's portfolio in Q2 2026, its #289 holding.
VarCov Co first reported a position in UiPath in Q4 2025 and has held it in 2 quarters since.
524 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on VarCov Co's 13F filing for Q2 2026, filed 14 Aug 2026.